Prebiotics are non-digestible carbohydrates that improve the animal health via modulation of their intestinal beneficial organisms. Immunowall® is a commercial prebiotic consists of high concentration of yeast β-glucan (βG) and Mannan-oligosaccharides (MOS). The current study was designed to investigate the prebiotic potential of Immunowall® on nutrition and health performance of Nile tilapia Oreochromis niloticus. Three fish groups were nourished on control diet supplemented with 0%, 0.1% and 0.2% Immunowall® for two months. Both dietary levels of Immunowall® exhibited significant increase in growth parameters (P ≤ 0.05) as well as in white blood cell count, total protein, and globulin concentrations. While, the immune parameters such as antioxidant biomarkers (catalase and glutathione-reductase), non-specific immune response (e.g. phagocytic activity, phagocytic index and lysozyme activity) and immune-related genes expressions (e.g. TNF-α and IL-1β) were higher in 0.2% Immunowall® compared to 0.1% Immunowall® and control. Oral administration of β-glucan and MOS mixture reduced the mortalities after microbial infections with L. gravieae and A. hydrophila. Therefore, we can recommend the dietary inclusion of Immunowall® in aqua-feed as an efficient method to achieve feasible and sustainable fish production.
No takes yet. Share an insight, caveat, or question.
Abu‐Elala et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: